186 related articles for article (PubMed ID: 38385073)
21. S100A9 maintains myeloid-derived suppressor cells in chronic sepsis by inducing miR-21 and miR-181b.
Alkhateeb T; Kumbhare A; Bah I; Youssef D; Yao ZQ; McCall CE; El Gazzar M
Mol Immunol; 2019 Aug; 112():72-81. PubMed ID: 31078118
[TBL] [Abstract][Full Text] [Related]
22. Stat3 and C/EBPβ synergize to induce miR-21 and miR-181b expression during sepsis.
McClure C; McPeak MB; Youssef D; Yao ZQ; McCall CE; El Gazzar M
Immunol Cell Biol; 2017 Jan; 95(1):42-55. PubMed ID: 27430527
[TBL] [Abstract][Full Text] [Related]
23. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
[TBL] [Abstract][Full Text] [Related]
24. Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation.
Fujimoto K; Uchida K; Yin E; Zhu J; Kojima Y; Uchiyama M; Yamamoto Y; Bashuda H; Matsumoto R; Tokushige K; Harada M; Inomata T; Kitaura J; Murakami A; Okumura K; Takeda K
Transpl Immunol; 2021 Aug; 67():101405. PubMed ID: 33975012
[TBL] [Abstract][Full Text] [Related]
25. Myeloid-Derived Suppressor Cells Mediate T Cell Dysfunction in Nonhuman Primate TB Granulomas.
Singh B; Singh DK; Ganatra SR; Escobedo RA; Khader S; Schlesinger LS; Kaushal D; Mehra S
mBio; 2021 Dec; 12(6):e0318921. PubMed ID: 34903057
[TBL] [Abstract][Full Text] [Related]
26. ANKRD22 is a potential novel target for reversing the immunosuppressive effects of PMN-MDSCs in ovarian cancer.
Chen H; Yang K; Pang L; Fei J; Zhu Y; Zhou J
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36822671
[TBL] [Abstract][Full Text] [Related]
27. Mediators of Inflammation-Driven Expansion, Trafficking, and Function of Tumor-Infiltrating MDSCs.
Tannenbaum CS; Rayman PA; Pavicic PG; Kim JS; Wei W; Polefko A; Wallace W; Rini BI; Morris-Stiff G; Allende DS; Hamilton T; Finke JH; Diaz-Montero CM
Cancer Immunol Res; 2019 Oct; 7(10):1687-1699. PubMed ID: 31439615
[TBL] [Abstract][Full Text] [Related]
28. Myeloid derived suppressor cells in peripheral blood can be a prognostic factor in canine transitional cell carcinoma.
Yokota S; Yonezawa T; Momoi Y; Maeda S
Vet Immunol Immunopathol; 2024 Mar; 269():110716. PubMed ID: 38308864
[TBL] [Abstract][Full Text] [Related]
29. CD115
Zou Y; Kamada N; Seong SY; Seo SU
Commun Biol; 2023 Mar; 6(1):272. PubMed ID: 36922564
[TBL] [Abstract][Full Text] [Related]
30. Modified method for differentiation of myeloid-derived suppressor cells
Zhou H; Xie Z; Morikawa N; Sakurai F; Mizuguchi H; Okuzaki D; Okada N; Tachibana M
Biochem Biophys Rep; 2023 Mar; 33():101416. PubMed ID: 36605123
[TBL] [Abstract][Full Text] [Related]
31. Blockade of Cycloxygenase-2 ameliorates sepsis induced immune-suppression by regulating myeloid-derived suppressor cells.
Chen J; Cai S; Li R; Xie J; Yang F; Liu T
Int Immunopharmacol; 2022 Mar; 104():108506. PubMed ID: 35008007
[TBL] [Abstract][Full Text] [Related]
32. LncRNA Snhg6 regulates the differentiation of MDSCs by regulating the ubiquitination of EZH2.
Lu W; Cao F; Feng L; Song G; Chang Y; Chu Y; Chen Z; Shen B; Xu H; Wang S; Ma J
J Hematol Oncol; 2021 Nov; 14(1):196. PubMed ID: 34794493
[TBL] [Abstract][Full Text] [Related]
33. mTOR inhibitor rapamycin induce polymorphonuclear myeloid-derived suppressor cells mobilization and function in protecting against acute graft-versus-host disease after bone marrow transplantation.
Lin Y; Wang B; Shan W; Tan Y; Feng J; Xu L; Wang L; Han B; Zhang M; Yu J; Yu X; Huang H
Clin Immunol; 2018 Feb; 187():122-131. PubMed ID: 29132870
[TBL] [Abstract][Full Text] [Related]
34. Transcriptomic profiling disclosed the role of DNA methylation and histone modifications in tumor-infiltrating myeloid-derived suppressor cell subsets in colorectal cancer.
Sasidharan Nair V; Saleh R; Toor SM; Taha RZ; Ahmed AA; Kurer MA; Murshed K; Alajez NM; Abu Nada M; Elkord E
Clin Epigenetics; 2020 Jan; 12(1):13. PubMed ID: 31941522
[TBL] [Abstract][Full Text] [Related]
35. The Voltage-Gated Hv1 H
Cozzolino M; Gyöngyösi A; Korpos E; Gogolak P; Naseem MU; Kállai J; Lanyi A; Panyi G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047188
[TBL] [Abstract][Full Text] [Related]
36. All-trans-retinoic acid restores CD4+ T cell response after sepsis by inhibiting the expansion and activation of myeloid-derived suppressor cells.
Liu T; Yang F; Xie J; Chen J; Gao W; Bai X; Li Z
Mol Immunol; 2021 Aug; 136():8-15. PubMed ID: 34051632
[TBL] [Abstract][Full Text] [Related]
37. mTOR Signaling Regulates the Development and Therapeutic Efficacy of PMN-MDSCs in Acute GVHD.
Li X; Li Y; Yu Q; Xu L; Fu S; Wei C; Wang L; Luo Y; Shi J; Qian P; Huang H; Lin Y
Front Cell Dev Biol; 2021; 9():741911. PubMed ID: 35004668
[TBL] [Abstract][Full Text] [Related]
38. Human myeloid-derived suppressor cell expansion during sepsis is revealed by unsupervised clustering of flow cytometric data.
De Zuani M; Hortová-Kohoutková M; Andrejčinová I; Tomášková V; Šrámek V; Helán M; Frič J
Eur J Immunol; 2021 Jul; 51(7):1785-1791. PubMed ID: 33788255
[TBL] [Abstract][Full Text] [Related]
39. Polymorphonuclear myeloid-derived suppressor cells play a proinflammatory role via TNF-α
Li M; Tang Z; Shu R; Wu H; Wang Y; Chen Z; Cheng Z; Yan X; Zhao N; Tang X; Zhang H; Sun L
Immunology; 2023 Oct; 170(2):286-300. PubMed ID: 37337447
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of CCL7 derived from Mo-MDSCs prevents metastatic progression from latency in colorectal cancer.
Ren X; Xiao J; Zhang W; Wang F; Yan Y; Wu X; Zeng Z; He Y; Yang W; Liao W; Ding Y; Liang L
Cell Death Dis; 2021 May; 12(5):484. PubMed ID: 33986252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
